Lanreotide – March 2026

Injection 60 mg (as acetate) in single dose pre-filled syringe, Injection 90 mg (as acetate) in single dose pre-filled syringe, Injection 120 mg (as acetate) in single dose pre-filled syringe

  • Brand names:
    • Lacreo®
  • Pharmaceutical Company:
    • SUN PHARMA ANZ PTY LTD
  • Condition/Indication: Acromegaly Functional carcinoid tumour. Non-functional gastroenteropancreatic neuroendocrine tumour (GEP-NET).
  • Meeting Date: March 2026
Public Summary Documents
Last updated
11 March 2026